Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 4	$ 136,964	$ (67,450)	$ 69,518
Balance (in Shares) at Dec. 31, 2021	37,855,114
Issuance of common stock upon exercise of stock options		13		13
Issuance of common stock upon exercise of stock options (in Shares)	19,073
Issuance of common stock upon exercise of common stock warrants
Issuance of common stock upon exercise of common stock warrants (in Shares)	20
Vesting of founders’ restricted stock		3		3
Stock-based compensation expense		778		778
Net loss			(2,207)	(2,207)
Balance at Mar. 31, 2022	$ 4	137,758	(69,657)	68,105
Balance (in Shares) at Mar. 31, 2022	37,874,207
Balance at Dec. 31, 2022	$ 4	141,120	(105,135)	35,989
Balance (in Shares) at Dec. 31, 2022	38,045,677
Issuance of common stock upon exercise of stock options		32		32
Issuance of common stock upon exercise of stock options (in Shares)	44,413
Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $6.6 million	$ 7	96,923		96,930
Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $6.6 million (in Shares)	69,000,000
Issuance of common stock through ATM offering, net of commissions and offering costs of $0.1 million		4,509		4,509
Issuance of common stock through ATM offering, net of commissions and offering costs of $0.1 million (in Shares)	2,337,496
Reclassification of common stock warrants from liability to equity (Note 7)		725		725
RSU settlements (in Shares)	625
Vesting of founders’ restricted stock		6		6
Stock-based compensation expense		1,267		1,267
Net loss			(14,260)	(14,260)
Balance at Mar. 31, 2023	$ 11	$ 244,582	$ (119,395)	$ 125,198
Balance (in Shares) at Mar. 31, 2023	109,428,211